Professor Stephen Boppart's Biophotonics Imaging Laboratory is focused on developing
novel optical biomedical diagnostic and imaging technologies, and translating them
into clinical applications. He is one of the early developers of the OCT technology,
and is actively participating in the growth, application, and clinical adoption of
this technology, including applications in cancer imaging, primary care imaging,
and the design and development of novel contrast agents specifically for OCT.
Professor Boppart completed his Ph.D. in Medical and Electrical Engineering from MIT,
and his M.D. from Harvard Medical School. He has over 200 invited and contributed
publications and over 30 patents related to optical biomedical imaging technology.
He has mentored over 80 undergraduate, graduate, and post-graduate interdisciplinary
researchers. He was recognized by MIT's Technology Review Magazine as one of the
Top 100 Young Innovators in the World for his development of medical technology,
received the IEEE Engineering in Medicine and Biology Early Career Award, and
recently, the Paul F. Forman Engineering Excellence Award from the Optical Society
of America for dedication and advancement in undergraduate research education.
He was Founding Director of the Mills Breast Cancer Institute at Carle Foundation
Hospital, Urbana, Illinois, and has worked to establish partnership ties between
the University of Illinois and local medical institutions. He is a Fellow of IEEE,
the Optical Society of America (OSA), and SPIE. Currently he holds a Bliss
Professorship of Engineering and is Director of a campus-wide Illinois Imaging
Initiative to integrate imaging science, technology, and applications across
multiple modalities and fields.
See also here